Allergy Associates of La Crosse / Research / Peer-reviewed Published Research by Allergy Associates of La Crosse Providers

Peer-reviewed Published Research by Allergy Associates of La Crosse Providers

The providers at Allergy Associates of La Crosse have a long history of being part of and driving additional research on sublingual immunotherapy in the U.S. Research dates back to the 1960s, when Dr. David Morris first published a paper on the use of allergy drops for food allergies. Since that time, they have conducted a number of patient studies and have partnered with leading allergy researchers and organizations to expand knowledge and further refine their approach to sublingual immunotherapy for food allergy, including peanut allergy, and environmental allergies.

Publications & Papers

Theodoropoulos DS, Kelly LE, Stockdale CK (2019), Celiac disease in the context of airborne allergen-associated chronic vulvovaginitis. Europ Rev Med & Pharmacol Sci 23(18):8084-8086

Kolchak NA, Tetarnikova MK, Theodoropoulou MS, Michalopoulou AP, Theodoropoulos DS (2017), Prevalence of antigliadin IgA antibodies in psoriasis vulgaris and response of seropositive patients to a gluten-free diet. J Multidiscip Healthc 11:13-19

Theodoropoulos DS, Theodoropoulou MS (2016), Pulmonary disease in beta-thalassemia. Curr Respir Med Rev 12(4):1-9

Theodoropoulos DS, Michalopoulou AP, Cullen NA, Stockdale CK (2016), Neuromodulation in allergic chronic vaginitis. Reprod Syst Sex Disord 5(4):1-7 DOI: 10.4172 / ISSN2161-038X. 1000197

Morris, M., Gupta, R., Progress Report on Sublingual Immunotherapy Research, FARE, June 2016.

DeBoer, D., Verbrugge, M., Morris, M. Clinical and immunological responses of dust mite sensitive, atopic dogs to treatment with sublingual immunotherapy (SLIT). Vet Dermatol 2016; 27: 82-87.

Theodoropoulos, D.S., Stockdale, C.K., Duquette, D.R., Morris, M.S., Inhalant allergy compounding the chronic vaginitis syndrome; characterization of sensitization patterns, comorbidities and responses to sublingual immunotherapy. Arch Gynecol Obstet, DOI 10.1007/s00404-016-4081-2.

Theodoropoulos, D.S., Morris, M.S., Morris, D.L., Sustained improvement of psoriatic lesions in the course of sublingual immunotherapy for airborne allergens: clinical evidence of cross-tolerance. European Review for Medical and Pharmacological Sciences (2015). 19: 392-395.

Morris, M., Lowery, A., Theodoropoulos, D., Duquette, R.D., Morris, D. Quality of life improvements with sublingual immunotherapy: a prospective study of efficacy. Journal of Allergy (2012). doi:

Theodoropoulos DS, Kanzenberger DR, Jones WM, Morris MS, Her C, Cullen NAM, Morris DL, Allergen-specific sublingual immunotherapy in the treatment of migraines: a prospective study. European Rev for Med and Pharm Sciences, 2011; 15: 1117-1121.

Morris MS, Bush RK, Swenson C et al, House Dust Mite Sublingual Immunotherapy: Results of a US Trial. Journal of Allergy & Clinical Immunology, [2011, 127(4):974-81.e1-7].

Theodoropoulos, D.S., Morris, M.S., Morris, D. Emerging concepts of sublingual immunotherapy for allergy. Drugs of Today 2009, 45(10); 737-750.

Thompson J.C., Morris M.S. Case reports by Cochard and Eigenmann. J Allergy Clin Immunol 2010; 125:277.

Morris DL, Kroker GF, Sabnis VJ, Morris MS, et al, The La Crosse Method Practice Protocol. 2006-2017.

Kroker G.F.: Concepts of Chemical Susceptibility, Part I, The Discovery of MCS, The Human Ecologist, vol 100, pgs 12-15, 2003.

Morris D.L., Morris M.S., Kroker, G.F. Sabnis V.K.: Local Immunotherapy in Allergy in Chem Immunol Allergy. Basel, Karger, 2003, vol 82, pp 1-10: Markert UR, Elsner P.

Morris D.L., Morris M.S., Kroker G.F., Sabnis V.K.: Annals of Allergy, Asthma and Immunology, Vol. 91, page 96, July 2003 (Letter to the Editor).

Morris, D.L., Current use of sublingual-swallow immunotherapy, Current Opinion in Otolaryngology & Head and Neck Surgery, Vol. 9, No. 3, pgs. 179-180, June 2001.

Morris, D.L. Intradermal Testing and Sublingual Desensitization for Nickel, Cutis, Vol. 61, No. 3, pgs. 129-132. March 1998.

Kroker G.F.: Chronic Candidiasis and Allergy. IN:  Food Allergy & Intolerance, ED: J. Brostoff. WB Saunders, November 1986.

Kroker G.F., Stroud R.M., Marshall R.T. et al:  Food Challenge Effects of Fasted Rheumatoid Arthritis:  A multicenter Study. Arch Clin Ecology 2(3): 137-144, 1984.

Kroker G.F.:  Randolph T.C., Marshall RT:  Acrylic Denture Sensitivity in Multiple Food and Chemical Sensitivities. Arch Elin Ecoloty 1:48-53, 1982.

Morris, D.L., Recognition and treatment of formaldehyde sensitivity, Clinical Ecology, Spring 1982, 27-30.

Morris, D.L., Treatment of Atopic Dermatitis with tolerogenic doses of antigen, Acta Dermatovener, 1980, 98-98.

Kroker G.F., Environmental Disease: The Phenomenon and the Problem. Annals of Allergy 42 (6): 395-396, 1979.

Morris, D.L., Value of Delayed Hypersensitivity Index in Patients with Malignancy, Annals of Allergy, 1977.

Morris, D., Treatment of respiratory disease with ultra-small doses of antigens. Annals of Allergy, Asthma & Immunology. 1970; 28(10): 494-500.

Morris, D., Use of sublingual antigen in diagnosis and treatment of food allergy. Annals of Allergy, Asthma, & Immunology. 1969; 27(6): 289-94.


American College of Allergy, Asthma & Immunology, Sublingual Immunotherapy for Peanut Allergy, Poster Presentation, November 2015.

New England Otolaryngological Society, Supporting Scientific Evidence for Sublingual Immunotherapy, December 2014.

World Allergy Organization, The effect and value of sublingual immunotherapy: a patient survey, Poster Presentation, December 2013.

American College of Allergy, Asthma & Immunology, Revealing Correlations Between Protein Allergen Components. Poster Presentation, November 2011.

American Academy of Allergy, Asthma & Immunonology, Allergen-specific IgE and IgG4 Measured by Microarray Technique in Patients with Clinical Improvement on Sublingual Immunotherapy. Poster Presentation, March 2011.

Allergychoices, Inc. La Crosse, WI. Sublingual Immunotherapy: Expanding Your Practice. January 2002, August 2002, February 2003, August 2004, August 2005, August 2006, August 2007, August 2008, August 2009, August 2012, August 2013, August 2014; Scottsdale, AZ, February 2011; Tampa, FL, February 2015.

American Academy of Allergy, Asthma & Immunology Safety of Sublingual Immunotherapy House Dust Mite Immunotherapy, Short Presentation. 2010.

American Academy of Allergy, Asthma & Immunology. High-dose House Dust Mite (HDM) Sublingual Immunotherapy (SLIT) Increases Antigen-Specific Serum IgG4 and PD20 to HDM Antigen. Poster Presentation. 2009.

American Osteopathic Colleges of Ophthalmology & Otolaryngology – Head & Neck Surgery, ENT Lecture on Sublingual Immunotherapy, 2008, October 2009.

American Academy of Physician Assistants in Allergy, Asthma, and Immunology, Update on SLIT—Where do we stand now? Boston, MA, August 2008.

American College of Allergy, Asthma & Immunology, Poster presentation, Sublingual Immunotherapy in the Treatment of Poison Ivy Dermatitis. Philadelphia, PA, November 2006.

American College of Allergy, Asthma & Immunology, Poster presentation An Economic Analysis of Sublingual Allergen Immunotherapy. Marcus Shaker MD; Carolyn Mohr BS, Martha Goodrich BS, Dartmouth-Hitchcock Medical Center, Lebanon NH; The Center for the Evaluative Clinical Sciences, Hanover NH; Mary Morris, MD, Allergy Associates of La Crosse, La Crosse WI. Philadelphia, PA. November 2006

American College of Allergy, Asthma & Immunology, Poster presentation, Impact of sublingual immunotherapy on allergic conditions associated with asthma in pediatric patients. Anaheim, CA. November 2005.

Back to Top